Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2015 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
TDOC on NYSE
Shares outstanding
175,611,455
Price per share
$5.74
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
132,160,914
Total reported value
$925,212,752
% of total 13F portfolios
0%
Share change
+7,295,148
Value change
+$48,211,277
Number of holders
333
Price from insider filings
$5.74
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 12% $183,075,446 21,018,995 The Vanguard Group 30 Jun 2025
BlackRock, Inc. 7.8% $99,368,053 13,556,351 BlackRock, Inc. 31 Mar 2025
Point72 Asset Management, L.P. 3.3% -34% $44,796,726 -$23,430,960 5,795,178 -34% Point72 Asset Management, L.P. 30 Sep 2025

As of 31 Dec 2025, 333 institutional investors reported holding 132,160,914 shares of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC). This represents 75% of the company’s total 175,611,455 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 21,483,707 -1.9% 0% $150,385,949
BlackRock, Inc. 8.1% 14,260,269 +2.8% 0% $99,821,883
RENAISSANCE TECHNOLOGIES LLC 4.5% 7,978,142 -2.4% 0.09% $55,846,994
DIMENSIONAL FUND ADVISORS LP 4.3% 7,494,255 +8.8% 0.01% $52,459,425
Point72 Asset Management, L.P. 3.2% 5,661,322 -1.8% 0.06% $39,629,254
STATE STREET CORP 2.4% 4,250,144 -8.8% 0% $29,751,008
GEODE CAPITAL MANAGEMENT, LLC 2.4% 4,188,313 +0.44% 0% $29,323,749
JUPITER ASSET MANAGEMENT LTD 2.2% 3,860,076 +294% 0.22% $27,020,532
Allianz Asset Management GmbH 1.8% 3,115,191 +92% 0.02% $21,806,337
AMERICAN CENTURY COMPANIES INC 1.8% 3,089,316 +509% 0.01% $21,625,212
Nuveen, LLC 1.5% 2,659,662 +39% 0% $18,617,634
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.5% 2,546,622 +0.18% 0% $17,826,351
Monaco Asset Management SAM 1.1% 1,956,947 +159% 4.1% $13,698,629
Pale Fire Capital SE 1.1% 1,944,203 1.8% $13,609,421
GOLDMAN SACHS GROUP INC 1.1% 1,924,533 -24% 0% $13,471,731
NORTHERN TRUST CORP 0.98% 1,727,509 -5% 0% $12,092,563
MORGAN STANLEY 0.95% 1,675,282 -53% 0% $11,726,979
Man Group plc 0.92% 1,620,633 +114% 0.02% $11,344,431
BNP PARIBAS FINANCIAL MARKETS 0.89% 1,557,832 0% 0.01% $10,904,824
AMERIPRISE FINANCIAL INC 0.86% 1,517,171 -34% 0% $10,620,197
MILLENNIUM MANAGEMENT LLC 0.86% 1,510,686 +407% 0.01% $10,574,802
UBS Group AG 0.85% 1,498,551 +25% 0% $10,489,857
TANG CAPITAL MANAGEMENT LLC 0.8% 1,400,000 0% 0.48% $9,800,000
Trexquant Investment LP 0.74% 1,307,952 0.08% $9,155,664
SG Americas Securities, LLC 0.74% 1,297,185 +320% 0.01% $9,080,000

Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 132,160,914 $925,212,752 +$48,211,277 $7.00 333
2025 Q3 123,376,453 $953,989,710 -$44,391,699 $7.73 349
2025 Q2 127,657,050 $1,111,810,150 +$28,908,039 $8.71 348
2025 Q1 124,764,453 $993,137,558 -$13,210,237 $7.96 368
2024 Q4 126,600,183 $1,150,909,215 +$5,732,507 $9.09 366
2024 Q3 125,343,265 $1,150,235,748 -$100,725,771 $9.18 352
2024 Q2 138,653,865 $1,356,107,775 +$78,896,049 $9.78 389
2024 Q1 129,813,184 $1,959,292,768 +$8,558,227 $15.10 411
2023 Q4 128,213,716 $2,762,470,436 +$64,064,682 $21.55 425
2023 Q3 124,707,305 $2,318,095,592 -$112,449,287 $18.59 418
2023 Q2 128,734,634 $3,259,624,540 -$197,804,335 $25.32 418
2023 Q1 136,344,301 $3,528,176,976 +$69,660,076 $25.90 416
2022 Q4 134,795,560 $3,187,915,143 -$88,463,415 $23.65 419
2022 Q3 137,929,338 $3,500,590,930 -$132,587,746 $25.35 421
2022 Q2 142,508,101 $4,752,897,156 -$35,457,280 $33.21 492
2022 Q1 135,294,586 $9,760,150,727 -$44,236,110 $72.13 640
2021 Q4 135,661,577 $12,464,617,010 -$96,730,604 $91.82 689
2021 Q3 133,460,521 $16,925,944,366 +$674,213,489 $126.81 738
2021 Q2 127,751,069 $21,259,926,344 +$1,036,756,412 $166.29 807
2021 Q1 121,322,454 $22,048,095,012 +$973,044,719 $181.75 873
2020 Q4 109,175,126 $21,828,607,477 +$6,575,258,095 $199.96 869
2020 Q3 75,563,046 $16,555,972,646 +$917,790,340 $219.24 730
2020 Q2 71,460,376 $13,644,498,539 -$180,652,715 $190.84 654
2020 Q1 72,838,954 $11,295,952,445 -$2,132,897,022 $155.01 559
2019 Q4 87,035,459 $7,286,337,875 -$311,263,665 $83.72 404
2019 Q3 90,856,564 $6,151,556,774 +$311,350,683 $67.72 365
2019 Q2 86,279,161 $5,708,002,798 +$184,430,573 $66.41 360
2019 Q1 84,967,430 $4,724,239,062 +$201,451,274 $55.60 355
2018 Q4 81,502,841 $4,039,756,305 +$65,534,475 $49.57 321
2018 Q3 78,683,955 $6,793,917,690 +$279,097,203 $86.35 330
2018 Q2 76,024,459 $4,413,324,206 -$62,794,723 $58.05 272
2018 Q1 77,172,756 $3,107,046,518 +$70,245,035 $40.30 229
2017 Q4 75,618,965 $2,635,297,138 +$300,630,734 $34.85 204
2017 Q3 65,338,332 $2,166,327,928 +$268,095,591 $33.15 177
2017 Q2 57,326,616 $1,989,441,272 +$288,789,640 $34.70 165
2017 Q1 50,788,462 $1,269,721,925 +$612,842,037 $25.00 131
2016 Q4 28,818,430 $475,514,658 +$62,340,869 $16.50 107
2016 Q3 24,591,861 $450,136,800 +$92,859,707 $18.31 101
2016 Q2 18,488,436 $296,177,335 +$63,261,690 $16.02 85
2016 Q1 15,770,964 $151,754,000 -$36,741,446 $9.60 78
2015 Q4 18,650,348 $334,951,386 -$60,380,110 $17.96 73
2015 Q3 20,870,768 $457,767,253 +$452,106,452 $22.29 88
2015 Q2 266,265 $5,009,000 +$5,009,000 $19.00 14